SG11202113053RA - Methods of otoprotection against platinum-based antineoplastic agents - Google Patents
Methods of otoprotection against platinum-based antineoplastic agentsInfo
- Publication number
- SG11202113053RA SG11202113053RA SG11202113053RA SG11202113053RA SG11202113053RA SG 11202113053R A SG11202113053R A SG 11202113053RA SG 11202113053R A SG11202113053R A SG 11202113053RA SG 11202113053R A SG11202113053R A SG 11202113053RA SG 11202113053R A SG11202113053R A SG 11202113053RA
- Authority
- SG
- Singapore
- Prior art keywords
- otoprotection
- methods
- antineoplastic agents
- based antineoplastic
- against platinum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/427,567 US10813947B1 (en) | 2019-05-31 | 2019-05-31 | Methods of otoprotection against platinum-based antineoplastic agents |
US201962886865P | 2019-08-14 | 2019-08-14 | |
PCT/US2020/035271 WO2020243536A1 (en) | 2019-05-31 | 2020-05-29 | Methods of otoprotection against platinum-based antineoplastic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202113053RA true SG11202113053RA (en) | 2021-12-30 |
Family
ID=73553934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202113053RA SG11202113053RA (en) | 2019-05-31 | 2020-05-29 | Methods of otoprotection against platinum-based antineoplastic agents |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3975722A4 (es) |
JP (1) | JP2022534617A (es) |
KR (1) | KR20220047217A (es) |
CN (1) | CN114302647A (es) |
AU (1) | AU2020284122A1 (es) |
BR (1) | BR112021023684A2 (es) |
CA (1) | CA3142153A1 (es) |
IL (1) | IL288532A (es) |
MX (1) | MX2021014447A (es) |
SG (1) | SG11202113053RA (es) |
WO (1) | WO2020243536A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0811175D0 (en) * | 2008-06-18 | 2008-07-23 | Prendergast Patrick T | Anti-tumour compositions and methods |
US8784870B2 (en) * | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
CA2767168C (en) * | 2009-07-08 | 2019-04-09 | Hope Medical Enterprises, Inc. D.B.A. Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
US10596190B2 (en) * | 2017-11-29 | 2020-03-24 | Oregon Health & Science University | Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy |
EP3986423A1 (en) * | 2019-06-19 | 2022-04-27 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Sodium thiosulfate gel for preventing or reducing hearing loss |
-
2020
- 2020-05-29 SG SG11202113053RA patent/SG11202113053RA/en unknown
- 2020-05-29 KR KR1020217042839A patent/KR20220047217A/ko unknown
- 2020-05-29 MX MX2021014447A patent/MX2021014447A/es unknown
- 2020-05-29 CA CA3142153A patent/CA3142153A1/en active Pending
- 2020-05-29 AU AU2020284122A patent/AU2020284122A1/en active Pending
- 2020-05-29 BR BR112021023684A patent/BR112021023684A2/pt unknown
- 2020-05-29 JP JP2021571025A patent/JP2022534617A/ja active Pending
- 2020-05-29 CN CN202080043662.0A patent/CN114302647A/zh active Pending
- 2020-05-29 EP EP20815470.8A patent/EP3975722A4/en active Pending
- 2020-05-29 WO PCT/US2020/035271 patent/WO2020243536A1/en unknown
-
2021
- 2021-11-29 IL IL288532A patent/IL288532A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3975722A1 (en) | 2022-04-06 |
MX2021014447A (es) | 2022-02-11 |
BR112021023684A2 (pt) | 2022-04-12 |
WO2020243536A1 (en) | 2020-12-03 |
CA3142153A1 (en) | 2020-12-03 |
CN114302647A (zh) | 2022-04-08 |
KR20220047217A (ko) | 2022-04-15 |
IL288532A (en) | 2022-01-01 |
EP3975722A4 (en) | 2023-02-08 |
JP2022534617A (ja) | 2022-08-02 |
AU2020284122A1 (en) | 2021-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201814169D0 (en) | Blockchain autonoumous agents | |
GB201801614D0 (en) | Formulation | |
PL3873245T3 (pl) | Formulacja ulegająca aerozolowaniu | |
IL290692A (en) | Salt | |
IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
IL282589A (en) | Aerosol formulation | |
IL293885A (en) | A computer-implemented fluid handling protocol | |
IL290815A (en) | History of alpha-d-galactopyranoside | |
IL284688A (en) | formulation | |
GB2570524B (en) | Fluency Aid | |
IL290525A (en) | Antimalarial agents | |
GB201807312D0 (en) | Formulation | |
IL288532A (en) | Methods of self-defense against platinum-based antiplastic agents | |
GB201913232D0 (en) | Aerosolisable formulation | |
MY174415A (en) | Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof | |
PL3800215T3 (pl) | Środek dyspergujący | |
GB2587402B (en) | Formulation | |
ZA202103578B (en) | Dna-cutting agent | |
ZA202103582B (en) | Dna-cutting agent | |
GB201916493D0 (en) | Firewall | |
GB2611435B (en) | Well insert | |
GB2597022B (en) | Well insert | |
GB2570736B (en) | Fluency aid | |
GB2570735B (en) | Fluency aid | |
GB2570734B (en) | Fluency Aid |